Status:

RECRUITING

Skills Group for Youth at Clinical High-Risk for Psychosis

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

Substance Abuse and Mental Health Services Administration (SAMHSA)

Conditions:

Clinical High-Risk

Psychological

Eligibility:

All Genders

13-18 years

Phase:

NA

Brief Summary

This study is intended to test the feasibility of an integrated cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills group for adolescents and young adults at clinical hi...

Detailed Description

The goal of the current study is to integrate cognitive behavioral therapy and dialectical behavioral therapy skills and implement in a group format to a sample of individuals at risk for developing a...

Eligibility Criteria

Inclusion

  • Participant
  • 13-18 years of age
  • Meet criteria for clinical high-risk syndrome (i.e., at clinical high risk for developing a psychotic disorder). CHR status is determined based off of scoring a 3 (moderate) - 5 (severe) on the Structured Interview for Psychosis-Risk Syndromes and/or having a first degree relative with psychotic disorder and/or the individual meets criteria for schizotypal personality disorder. Additionally individuals with a brief intermittent psychotic symptoms can be included as well (e.g., frankly psychotic symptoms that are very brief)
  • Individuals must be enrolled in the HOPE team at the University of Pittsburgh since this group is embedded within that service
  • Participation

Exclusion

  • Group member meeting criteria for a current/past psychotic disorder
  • Inclusion Criteria for Parents or Legal Guardians:
  • Must be the parent, legal guardian of a 13-18 year-old
  • For parents of CHR adolescents, their adolescent must meet criteria for a psychosis-risk syndrome

Key Trial Info

Start Date :

April 26 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05398120

Start Date

April 26 2022

End Date

January 1 2026

Last Update

December 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Bellefield Towers

Pittsburgh, Pennsylvania, United States, 15213